Purchase Order 75N92019P00343

The National Institutes of Health Clinical Center awarded a purchase order to Genewiz, LLC valued at $43,320.00 on October 1, 2020, for payment to cover invoices not submitted until June 2021. Performance took place in Bethesda, Maryland. The order was issued as firm fixed price with no set-aside designation. The ultimate completion date was October 5, 2020. Genewiz provides genomic services including gene synthesis, next-generation sequencing, and bioinformatics analysis to support federal...

<p>The National Heart Lung and Blood Institute issued a $108,771 delivery order to Illumina, Inc. on December 19, 2014, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order is firm fixed price with an ultimate completion date of August 31, 2015. The source does not identify the parent IDIQ or GWAC vehicle under which this delivery order was issued.</p>

<p>The National Cancer Institute awarded a purchase order to Genewiz, LLC for sequencing services valued at $5,148.00, with an award date of May 16, 2018 and completion deadline of June 14, 2018. Work is performed at Genewiz's facility in South Plainfield, New Jersey. The order is priced firm fixed price with no set-aside applied.</p>

<p>The National Heart Lung and Blood Institute issued a $38,844 delivery order to Illumina, Inc. on November 4, 2014, for genetic sequencing and genomic analysis equipment and materials, with an ultimate completion date of August 31, 2015.</p> <p>Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation. The source does not identify the parent vehicle under which this delivery order was issued.</p>

<p>The National Heart Lung and Blood Institute issued an $8,290 delivery order to Illumina, Inc. on July 8, 2015, for genetic sequencing supplies and services with a completion date of July 17, 2015.</p> <p>Place of performance is Bethesda, MD. The order is priced firm fixed price. No parent IDV or GWAC vehicle is identified in the source materials provided.</p>

<p>The National Heart Lung and Blood Institute issued a $45,211.40 delivery order to Illumina, Inc. on June 24, 2020, for genetic sequencing and genomic analysis equipment and consumables.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed price with an ultimate completion date of September 2, 2020. No set-aside was used. The source does not identify a parent IDIQ or GWAC vehicle for this delivery order.</p>

<p>The National Heart Lung and Blood Institute issued a purchase order to Appistry, Inc. for $100,000.00 on June 2, 2014, to cover sequencing of up to 60 whole genomes. Performance takes place in St. Louis, Missouri, with ultimate completion on June 1, 2015. The order carries firm fixed-price terms and no small business set-aside.</p>

<p>The National Heart Lung and Blood Institute issued a $31,987.71 delivery order to Illumina, Inc. on May 23, 2019, for genetic sequencing and genomic analysis equipment and services, with ultimate completion by September 2, 2020.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed-price with no set-aside designation.</p>

<p>The National Heart Lung and Blood Institute issued a $10,697 delivery order to Illumina, Inc. on August 17, 2015, for genetic sequencing and genomic analysis equipment and consumables.</p> <p>Place of performance is Bethesda, MD. The order is firm fixed price with an ultimate completion date of August 31, 2015. No set-aside was used.</p>

<p>The National Heart Lung and Blood Institute issued a $61,208.46 delivery order to Illumina, Inc. on September 14, 2015, for genetic sequencing and genomic analysis equipment and reagents.</p> <p>Place of performance is Bethesda, MD. The order carried a firm fixed-price structure with an ultimate completion date of September 2, 2020. No set-aside was used.</p>